Cholesterol drug shows promise in fighting effects of malaria
Friday, December 28, 2012 - 10:30
in Health & Medicine
Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects against cognitive impairment in a mouse model of cerebral malaria.